Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 211 to 225 of 529 results for physical activity

  1. What key factors influence differences in walking and cycling behaviour among different groups – and what are the implications for interventions aiming to achieve population-level change and reduce inequalities?

    ownership. Source guidance details Comes from guidance Physical activity: walking and cycling Number PH41 Date issued

    Research recommendation
    Published
    9 June 2015

  2. Unintentional injuries on the road: interventions for under 15s (PH31)

    This guideline covers road speed limits, 20 mph zones and engineering measures to reduce speed or make routes safer.

    Public health guideline
    Published
    24 November 2010
    View recommendations

    Sections for PH31

  3. What key factors ensure people continue to walk or cycle in the long term (over a year)? How do individual interventions (such as follow-up or goal-setting) interact with environmental factors (such as distance, perception of danger or provision of facilities) in encouraging people to continue to walk or cycle?

    None. Source guidance details Comes from guidance Physical activity: walking and cycling Number PH41 Date issued

    Research recommendation
    Published
    9 June 2015

  4. What key factors influence the effectiveness of population-level or whole-area approaches to encouraging walking or cycling? How do these factors interact?

    areas? Source guidance details Comes from guidance Physical activity: walking and cycling Number PH41 Date issued

    Research recommendation
    Published
    9 June 2015

  5. Contraceptive services for under 25s (PH51)

    This guideline covers contraceptive services for under-25s. It aims to ensure all under-25s are given advice and information on all types of contraception. This includes additional tailored support to meet the particular needs and choices of those who are socially disadvantaged or who may find it difficult to use these services.

    Public health guideline
    Published
    26 March 2014
    View recommendations

    Sections for PH51

  6. Hypersexuality: fluoxetine (ESUOM46)

    Summary of the evidence on fluoxetine for treating hypersexuality to inform local NHS planning and decision-making

    Evidence summary
    Published
    21 July 2015

  7. Rehabilitation after critical illness in adults (QS158)

    This quality standard covers adults with rehabilitation needs as a result of critical illness that required level 2 or level 3 critical care. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    7 September 2017
    View quality statements

    Sections for QS158

  8. How do individual and local factors influence the effectiveness of specific approaches to encouraging walking or cycling?

    planning? Source guidance details Comes from guidance Physical activity: walking and cycling Number PH41 Date issued

    Research recommendation
    Published
    9 June 2015

  9. Lifestyle factors to reduce the risk of pelvic floor dysfunction: What lifestyle factors reduce the risk of developing pelvic floor dysfunction (diet, reducing carbonated drink and caffeine intake)?

    made the recommendation for research, see the rationale section on physical activity and diet and other modifiable risk factors. Full...

    Research recommendation
    Published
    7 January 2022

  10. Faecal incontinence in adults: management (CG49)

    This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis. It aims to improve the physical and mental health and quality of life of people with faecal incontinence.

    Clinical guideline
    Published
    27 June 2007
    View recommendations

    Sections for CG49

  11. Sarilumab for moderate to severe rheumatoid arthritis (TA485)

    Evidence-based recommendations on sarilumab (Kevzara) for treating moderate to severe rheumatoid arthritis in adults.

    Technology appraisal guidance
    Published
    1 November 2017
    View recommendations

    Sections for TA485

  12. Stage 4: treatment, assessment and monitoring

    In virtual wards, people can receive virtual and technology-assisted treatment, assessment, and monitoring.

  13. How could existing guidance on evaluating complex, population-wide interventions be most usefully adapted and applied to approaches that aim to increase rates of walking and cycling?

    regeneration. Source guidance details Comes from guidance Physical activity: walking and cycling Number PH41 Date issued

    Research recommendation
    Published
    9 June 2015

  14. Anakinra for treating Still's disease (TA685)

    Evidence-based recommendations on anakinra (Kineret) for treating adult-onset Still’s disease and systemic juvenile idiopathic arthritis in people 8 months and older.

    Technology appraisal guidance
    Published
    31 March 2021
    View recommendations

    Sections for TA685

  15. Partial replacement of the meniscus of the knee using a biodegradable scaffold (HTG289)

    Evidence-based recommendations on partial replacement of the meniscus of the knee using a biodegradable scaffold. This involves placing a biodegradable implant into the meniscus to support regrowth and repair of the damage.

    HealthTech guidance
    Published
    23 July 2012
    View recommendations

    Sections for HTG289